When to sell LLY
The honest answer to "when should I sell ELI LILLY & Co" is not a price target. It is the moment the reasons you bought it stop being true. Here is a thesis-based checklist for LLY holders.
The LLY sell checklist
- 1Did a reason break, or just the price? A drawdown with your thesis intact is not a sell signal. A contradicted pillar is.
- 2Check the latest filing and earnings Read what changed against your reasons for owning LLY, not against the stock chart.
- 3Look for the specific risks LLY's known risks are below. Watch for any of them turning from possibility into fact.
- 4Re-underwrite, do not anchor If a reason is gone, decide whether you would buy LLY today on what remains. If not, the position is a hold by inertia.
What you bought LLY for
Some investors cite Eli Lilly's strong revenue growth of 44.70% and an EPS growth of 95.99% as indicators of robust business performance. Additionally, the company raised its 2026 sales forecast to as much as $92B, reflecting optimism about future demand, particularly for its obesity drug.
The signals that would break it
Conversely, concerns exist regarding Eli Lilly's high P/E ratio of 62.15, which may indicate overvaluation relative to earnings. Furthermore, the company's D/E ratio of 1.54 suggests a reliance on debt that could pose risks in a rising interest rate environment.
Where LLY stands now
Eli Lilly & Co has a market capitalization of approximately $1.28T and is currently priced at $1426.45, reflecting a change of +3.89% from the previous close of $1372.99. The stock has seen a day range between $1406.97 and $1447.86, with a P/E ratio of 62.15 and an impressive year-over-year EPS growth of 95.99%. Revenue growth year-over-year stands at 44.70%, and the company maintains a dividend yield of 0.42%.
The hard part is noticing
Everyone agrees you should sell when the reasons change. The problem is that the evidence lives in filings and earnings calls, while you spend your attention on the price. Helm closes that gap: you write the reasons you own LLY, and Helm watches the primary sources against them, then tells you with a dated citation when one breaks. See how thesis monitoring works, or read what could invalidate the LLY thesis.
Common questions
When should I sell LLY?
Sell ELI LILLY & Co when the specific reasons you bought it are contradicted by a filing, an earnings result, or a material news event, not merely when the price falls. A lower price with the thesis intact is a different situation from a broken thesis.
What are the warning signs for LLY?
The main risks to watch: Conversely, concerns exist regarding Eli Lilly's high P/E ratio of 62.15, which may indicate overvaluation relative to earnings. Furthermore, the company's D/E ratio of 1.54 suggests a reliance on debt that could pose risks in a rising interest rate environment.
Is a falling LLY price a reason to sell?
Not by itself. Price is not a reason. The question is whether the reasons you own LLY still hold. If they do, a drawdown may be noise; if they do not, the position deserves a fresh decision regardless of price.
Know the moment, not the price.
Helm tells you, with a dated source, when the LLY thesis breaks. Free to start.
Take the helmThis content is for educational purposes only and does not constitute financial, tax, or investment advice. Helm Terminal is not a registered investment advisor.